Found: 6
Select item for more details and to access through your institution.
Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241274592
- By:
- Publication type:
- Article
In vitro and clinical investigations to determine the drug-drug interaction potential of entrectinib, a small molecule inhibitor of neurotrophic tyrosine receptor kinase (NTRK).
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 68, doi. 10.1007/s10637-021-01156-9
- By:
- Publication type:
- Article
Characterization of the pharmacokinetics of entrectinib and its active M5 metabolite in healthy volunteers and patients with solid tumors.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 3, p. 803, doi. 10.1007/s10637-020-01047-5
- By:
- Publication type:
- Article
Physiologically Based Absorption Modelling to Explore the Impact of Food and Gastric pH Changes on the Pharmacokinetics of Entrectinib.
- Published in:
- AAPS Journal, 2020, v. 22, n. 4, p. 1, doi. 10.1208/s12248-020-00463-y
- By:
- Publication type:
- Article
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 3, p. 1, doi. 10.1111/cts.13730
- By:
- Publication type:
- Article
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 3, p. 239, doi. 10.1007/s00280-023-04510-1
- By:
- Publication type:
- Article